(Q80611754)
Statements
Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers (English)
Stéphane Culine
Mounira El Demery
François Iborra
Christophe Avancès
844-8; discussion 848